Heparin versus bivalirudin for percutaneous coronary intervention: has the debate come to an end?
Sign Up to like & getrecommendations! Published in 2017 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2017.10.23
Abstract: Percutaneous coronary intervention (PCI) is the cornerstone of management for patients with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) (1-6). Anticoagulation is routinely administered during PCI in order to minimize the risk of… read more here.
Keywords: heparin versus; versus bivalirudin; bivalirudin percutaneous; percutaneous coronary ... See more keywords